Treatment of Forehead/Glabellar Rhytide Complex With Onabotulinum Toxin A Versus Incobotulinum Toxin A Injection: A Split-face, Double-blinded, Randomized Control Trial

Trial Profile

Treatment of Forehead/Glabellar Rhytide Complex With Onabotulinum Toxin A Versus Incobotulinum Toxin A Injection: A Split-face, Double-blinded, Randomized Control Trial

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 09 Dec 2016

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Skin wrinkles
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Dec 2016 Planned End Date changed from 1 Nov 2016 to 1 Dec 2017.
    • 05 Dec 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Dec 2017.
    • 11 Feb 2016 Planned End Date changed from 1 Nov 2015 to 1 Nov 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top